![](/img/cover-not-exists.png)
LONG-TERM PROTEASOME INHIBITION (LTPI) IN PATIENTS (PTS) WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): US MM-6, A REAL-WORLD (RW) STUDY TRANSITIONING FROM BORTEZOMIB (BTZ) TO IXAZOMIB (IXA)
Rifkin, R. M., Yimer, H. A., Noga, S. J., Manda, S., Birhiray, R., Yasenchak, C., Lyons, R., Kelly, P., Chojnicki, E., Whidden, P., Wang, B., Demers, B., Dollar, L., Boccia, R.Volume:
3
Journal:
HemaSphere
DOI:
10.1097/01.hs9.0000561200.43482.59
Date:
June, 2019
File:
PDF, 255 KB
2019